tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:0QAJ Stock Latest News

DBV Technologies announces Phase 3 Vitesse trial met primary endpoint
The FlyDBV Technologies announces Phase 3 Vitesse trial met primary endpoint
1d ago
DBVT
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
PremiumThe Fly
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
3M ago
PG
ABM
DBV Technologies price target raised to $40 from $35 at H.C. Wainwright
PremiumThe Fly
DBV Technologies price target raised to $40 from $35 at H.C. Wainwright
3M ago
DBVT
DBV Technologies price target raised to $48 from $42 at Cantor Fitzgerald
PremiumThe Fly
DBV Technologies price target raised to $48 from $42 at Cantor Fitzgerald
3M ago
DBVT
Optimistic Buy Recommendation for DBV Technologies Driven by Viaskin Peanut’s Strong Clinical Results and Market Potential
PremiumRatings
Optimistic Buy Recommendation for DBV Technologies Driven by Viaskin Peanut’s Strong Clinical Results and Market Potential
3M ago
DBVT
DBV Technologies price target raised to $51 from $35 at Guggenheim
PremiumThe FlyDBV Technologies price target raised to $51 from $35 at Guggenheim
3M ago
DBVT
DBV Technologies price target raised to $45 from $21 at Citizens
Premium
The Fly
DBV Technologies price target raised to $45 from $21 at Citizens
3M ago
DBVT
DBV Technologies trading resumes, shares up 65% to $29.60
Premium
The Fly
DBV Technologies trading resumes, shares up 65% to $29.60
3M ago
DBVT
DBV Technologies jumps 79% after peanut allergy study hits endpoint
PremiumThe Fly
DBV Technologies jumps 79% after peanut allergy study hits endpoint
3M ago
DBVT
DBV Technologies trading resumes
PremiumThe Fly
DBV Technologies trading resumes
3M ago
DBVT
DBV Technologies reports VITESSE trial meets primary endpoint
PremiumThe Fly
DBV Technologies reports VITESSE trial meets primary endpoint
3M ago
DBVT
DBV Technologies trading halted, news pending
PremiumThe Fly
DBV Technologies trading halted, news pending
3M ago
DBVT
DBV Technologies initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyDBV Technologies initiated with an Overweight at Cantor Fitzgerald
3M ago
DBVT
DBV Technologies price target raised to $35 from $20 at H.C. Wainwright
Premium
The Fly
DBV Technologies price target raised to $35 from $20 at H.C. Wainwright
3M ago
DBVT
DBV Technologies initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
DBV Technologies initiated with an Overweight at Cantor Fitzgerald
3M ago
DBVT
Guggenheim starts DBV Technologies at Buy on peanut allergy market potential
PremiumThe Fly
Guggenheim starts DBV Technologies at Buy on peanut allergy market potential
3M ago
DBVT
DBV Technologies initiated with a Buy at Guggenheim
PremiumThe Fly
DBV Technologies initiated with a Buy at Guggenheim
3M ago
DBVT
Optimistic Buy Rating for DBV Technologies Amid Promising VIASKIN Peanut Trial Developments
PremiumRatings
Optimistic Buy Rating for DBV Technologies Amid Promising VIASKIN Peanut Trial Developments
3M ago
DBVT
DBV Technologies announces last patient visit completed in VITESSE trial
PremiumThe Fly
DBV Technologies announces last patient visit completed in VITESSE trial
4M ago
DBVT
DBV Technologies appoints Kevin Trapp as chief commercial officer
PremiumThe FlyDBV Technologies appoints Kevin Trapp as chief commercial officer
4M ago
DBVT
DBV Technologies price target raised to $20 from $16 at H.C. Wainwright
Premium
The Fly
DBV Technologies price target raised to $20 from $16 at H.C. Wainwright
4M ago
DBVT
DBV Technologies reports Q3 GAAP EPS (24c), consensus (29c)
Premium
The Fly
DBV Technologies reports Q3 GAAP EPS (24c), consensus (29c)
4M ago
DBVT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >